Minnesota Attorney General Mike Hatch is planning to file litigation against drug maker Pharmacia for alleged "price fraud" on some chemotherapy drugs.



/index.php?option=com_iwpfile&file=/dir_01/he2002_2196.pdf


/index.php?option=com_iwpfile&file=/dir_01/he2002_2195.pdf




/index.php?option=com_iwpfile&file=/dir_01/he2002_2193.pdf


/index.php?option=com_iwpfile&file=/dir_01/he2002_2192.pdf


re

The House Ways and Means Committee today (Aug. 16) released a recent letter from CMS Administrator Tom Scully, in which the agency chief signals strong support for making competitive bidding for durable medical equipment (DME) a permanent part of Medicare. The House-passed Medicare reform bill includes a provision that would allow DME suppliers to competitively bid for contracts with CMS.



/index.php?option=com_iwpfile&file=/dir_01/he2002_2191.pdf


/index.php?option=com_iwpfile&file=/dir_01/he2002_2189.pdf


ng

FOR IMMEDIATE RELEASE

August 15, 2002

STATEMENT

(Statement from Dr. Lester Crawford, deputy commissioner of the Food and Drug Administration, regarding Metabolife.)

Three weeks ago, we asked the Department of Justice to pursue a criminal investigation of Metabolife - whether they made false statements to FDA regarding the existence of adverse event reports.



Pages

Log in to access this content.

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.